New blood test could forecast head and neck cancer progression

NCT ID NCT06678724

Recruiting now Knowledge-focused Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Feb 25, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This observational study enrolls 30 adults with recurrent or metastatic head and neck squamous cell carcinoma. Researchers will collect blood samples to measure circulating tumor cells and immune cell activity, aiming to link these markers with how long patients live without the disease worsening. The goal is to better predict prognosis and understand how different treatments affect the tumor environment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-••••

Locations

National Taiwan University HsinChu Branch
RECRUITING

Zhubei, HsinChu County, 302058, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

HEAD AND NECK CANCER METASTATIC HEAD AND NECK CANCERS- SQUAMOUS CELL RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA